CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 144 Insider Sale of Securities
- 4 Planned sale Chief Accounting Officer sold 750 shares at $175.22 ($131,415)
- 4 Shares withheld for taxes President, R&D gave up 43,877 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 43,877 shares (to pay taxes)
- 8-K Event Exhibits
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale President, R&D sold 50,000 shares at an average $164.80 ($8,240,023)
- 4 Planned sale President and CEO sold 50,000 shares at an average $164.80 ($8,240,023)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
Page 6 of 26 · 513 filings